Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026)
Arcus Biosciences (RCUS) recorded quarterly Interest & Investment Income of $9.0 million in Q1 2026, down 10.0% quarter-over-quarter from $10.0 million in Q4 2025, and down 18.18% on a YoY basis from $11.0 million in Q1 2025.
Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026) Analysis & Trends
Arcus Biosciences' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 18.18% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $39.0 million (down 22.0% YoY), while the FY2025 annual figure was $41.0 million, down 21.15% from the prior year.
- Interest & Investment Income was $9.0 million for Q1 2026 at Arcus Biosciences, down from $10.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $14.0 million in Q3 2024 to a low of $582000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $9.4 million across 5 years, with a median of $10.0 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 3005.59% in 2022, then dropped 28.57% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $8.0 million in 2022, then surged by 37.5% to $11.0 million in 2023, then rose by 9.09% to $12.0 million in 2024, then retreated by 16.67% to $10.0 million in 2025, then fell by 10.0% to $9.0 million in 2026.
- The last three Interest & Investment Income figures came in at $9.0 million (Q1 2026), $10.0 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Arcus Biosciences | 3.05 Bn | 2.23 Bn | - | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 582,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Sep 30, 2021 | 161,000.00 |
| Jun 30, 2021 | 166,000.00 |